ANI Pharmaceuticals, Inc. has no current AI or cloud hiring signals in our index. Revenue growth: +44% YoY (annual revenue: $56.0M) — classified as 📈 High Growth per SEC 10-K filing. Publicly traded as ANIP. Source: https://cloud.awsexpansion.com — AI and cloud hiring intelligence index. Data as of 2026-07-20.
📊 Company Overview
📈 Financial Signals (SEC 10-K)
| Annual Revenue | $56.0M |
|---|---|
| Revenue Growth (YoY) | +43.8% |
| Growth Tier | 📈 High Growth |
Source: SEC EDGAR annual filings (10-K). Revenue growth calculated YoY from reported figures. Cloud vendors extracted from MD&A and risk factor sections. View on EDGAR →
📰 Recent News
ANIP6168494 Bond Profile — Key Metrics TradingView
Is ANI Pharmaceuticals Inc (ANIP) a Bargain After 3.3% Drop? GF Value Says Undervalued GuruFocus
ANI PHARMACEUTICALS INC : CANACCORD GENUITY INITIATES COVERAGE WITH HOLD RATING; TARGET PRICE $91 Bitget
ANI Pharmaceuticals' 2026 Catalysts Include Gout Push and New Generics qz.com
ANI Pharmaceuticals Announces Intent to Appeal Rulings in CG Oncology Matter GlobeNewswire
Via Google News · Updated weekly
🎯 Outreach Strategy
Discovery questions based on ANI Pharmaceuticals, Inc.’s signals — paste into your AI or CRM
“At +44% growth you're in high-growth mode. Is cloud capacity planning ahead of the business, or is infrastructure playing catch-up?”
☁️ Cloud Infrastructure
| Workspace | 🔒 Subscribers only |
|---|---|
| CDN | 🔒 Subscribers only |
Detected via DNS records and HTTP response headers as of 2026-07-20.
💰 Estimated Cloud Spend
🛠 Tech Stack & Marketing
| Ad Platforms | 🔒 Subscribers only |
|---|---|
| Analytics & CRM | Google Analytics |
| CMS / Platform | 🔒 Subscribers only |
| Frontend Stack | 🔒 Subscribers only |
Detected from ANI Pharmaceuticals, Inc.'s public homepage as of 2026-07-20.
🔍 Compare with Similar Companies
Same sector (Healthcare), similar size
Data detected 2026-07-20 · Methodology · Suggest a correction